Published by Josh White on 4th October 2022
(Sharecast News) - Infectious disease pharmaceutical company Poolbeg Pharma updated the market on its intellectual property (IP) position around 'POLB 001' on Tuesday, which it described as a small molecule immunomodulator for the treatment of severe influenza.
URL: http://www.digitallook.com/dl/news/story/33009159/...